Bottom cards (Which this is) does not render the title text, so what you put here doesn't matter.

‘World’s biggest quango’: The history of NHS England and what its abolition may look like

Expansion of OpenSAFELY: What it means for GP patient data

Will mummy make it better? The curious case of mummified remedies in early modern medicine

What will it take to improve palliative care to give patients a 'meaningful choice'? 

Analysis and Opinion

# The news that impacts UK doctors

Tirzepatide, a glucagon-like peptide-1 (GLP-1) agonist – sold under the brand name Mounjaro which is made by Eli Lilly – was recommended to treat obesity on the NHS in England earlier this year.

Women lose more weight than men on tirzepatide, analysis finds

Log in or join for free to read more

You might also like